DraftKings (DKNG) Q1 2026 Earnings Transcript

DraftKings reported Q1 revenue of $1.6 billion, up 17% year over year, and adjusted EBITDA of $168 million, up 64%, while also posting positive net income for a second straight quarter and repurchasing nearly $100 million of stock. Management reaffirmed full-year 2026 guidance of $6.5 billion to $6.9 billion in revenue and $700 million to $900 million in adjusted EBITDA, but said it plans to invest $200 million to $300 million in Predictions this year. Sportsbook revenue rose 24% to $1.1 billion, with margin expanding 140 bps to 7.8%, and April trends remained strong with handle up 6% and revenue up 22%.

Analysis

The key read-through is that DKNG is trying to convert a sports-betting franchise into a multi-layer transaction platform before competitors can normalize prediction markets. The near-term economic signal is actually better than the headline guide implies: if customer acquisition really stays this efficient, management can slow spend faster than the market expects and preserve upside to the core EBITDA bridge. The hidden beneficiary is not just DKNG’s equity story but also its bargaining power with media/affiliate partners, since a unified app with higher engagement should reduce dependence on paid traffic over the next 2-4 quarters.

The bigger second-order effect is that predictions may be more disruptive to the existing sportsbook oligopoly than to casino. If users migrate into a more frequent-trading, lower-friction product, the winner is the operator with the best pricing engine, liquidity management, and cross-sell architecture; that favors DKNG versus smaller books, but it also raises the bar on risk controls and regulatory hygiene. The early evidence that losses can accrue faster than conventional sports bets is the part to watch: if consumer-protection concerns escalate, the category could face tighter product constraints just as marketing spend ramps into the World Cup window.

Contrarian angle: the market may be over-penalizing the incremental Predictions investment while underestimating how much of it is actually an option on future distribution. The more important question is whether predictions CAC stays structurally low after the novelty phase; if it does, 2027 becomes an inflection year for operating leverage, but if it reverts, this looks like another expensive adjacency with limited moat. I’d also note the company’s own willingness to pull back spend means the downside is more in foregone upside than permanent impairment, which should limit multiple compression unless regulatory headlines deteriorate sharply over the next 1-2 quarters.

Key Decisions for Investors

• Go long DKNG into any post-print weakness over the next 1-3 weeks; the setup favors buying when the market focuses on the $200M-$300M Predictions spend and ignores the implied flexibility to throttle back if CAC weakens. Target 8-12% upside over 3-6 months if core EBITDA keeps re-rating.
• Pair trade: long DKNG / short FLUT for 2-4 quarters. DKNG has the cleaner super-app and better optionality in predictions; FLUT is more exposed to the market’s skepticism around sportsbook maturity and has less visible near-term product leverage.
• Buy DKNG Jan-2027 calls with strikes ~15-20% above spot. This is a levered way to express the view that predictions becomes an EBITDA contributor after the initial investment phase; risk is capped premium if regulatory scrutiny hits faster than expected.
• Use a tight stop on any DKNG long if there is evidence that Predictions CAC re-accelerates or consumer-protection commentary intensifies over the next 30-60 days; that would invalidate the ‘cheap optionality’ thesis and turn this into a spend trap.